Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

[{"orgOrder":0,"company":"Evofem Biosciences","sponsor":"Windtree Therapeutics","pharmaFlowCategory":"D","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Other Small Molecule","year":"2025","type":"Licensing Agreement","leadProduct":"L-Lactic Acid","moa":"||Vaginal pH","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Approved FDF","graph3":"Evofem Biosciences","amount2":0,"highestDevelopmentShortName":"","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Vaginal Gel","sponsorNew":"Evofem Biosciences \/ Windtree Therapeutics","highestDevelopmentStatusID":"15","companyTruncated":"Evofem Biosciences \/ Windtree Therapeutics"}]

Find Clinical Drug Pipeline Developments & Deals for (+/-)-Lactic acid

(+/-)-Lactic acid
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check COS database
Check all USDMF suppliers

Contact Us
PharmaScopic.com

(+/-)-Lactic acid

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 5 USDMF, 1 JDMF, 7 Listed Suppliers, $ API Reference Price

13 API Suppliers
5 USDMF
1 JDMF
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

109 FDF Dossiers, 16 FDA Orange Book, 56 Europe, 29 Canada, 2 Australia, 6 Listed Dossiers

109 FDF Dossiers
16 FDA Orange Book
56 Europe
29 Canada
2 Australia
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML), INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)

INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 2 Rochem International Inc, 2 SPI Pharma, 8 DKSH, 1 Pharm-RX Chemical, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 10 Actylis, 6 BASF, 1 BioSpectra, 5 Corel Pharma Chem, 3 Finar, 6 Gangwal Chemicals, 1 Hayashibara, 2 Ideal Cures Pvt Ltd, 7 Kerry, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 1 Nanjing Bold Chemical, 1 Novo Excipients, 2 Pluviaendo, 1 Qualicaps, 16 Roquette, 8 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

23 Coating Systems & Additives, 22 Parenteral, 21 Topical, 19 Solubilizers, 16 Thickeners and Stabilizers, 16 Film Formers & Plasticizers, 13 Fillers, Diluents & Binders, 9 Taste Masking, 8 Empty Capsules, 6 Emulsifying Agents, 6 Controlled & Modified Release, 5 Co-Processed Excipients, 4 Granulation, 4 Surfactant & Foaming Agents, 4 Direct Compression, 3 API Stability Enhancers, 3 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 2 Disintegrants & Superdisintegrants, 2 Coloring Agents, 1 Soft Gelatin

23 Coating Systems & Additives
22 Parenteral
21 Topical
19 Solubilizers
16 Thickeners and Stabilizers
16 Film Formers & Plasticizers
13 Fillers, Diluents & Binders
9 Taste Masking
8 Empty Capsules
6 Emulsifying Agents
6 Controlled & Modified Release
5 Co-Processed Excipients
4 Granulation
4 Surfactant & Foaming Agents
4 Direct Compression
3 API Stability Enhancers
3 Rheology Modifiers
2 Chewable & Orodispersible Aids
2 Disintegrants & Superdisintegrants
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 18 News #PharmaBuzz

1 Data Compilation #PharmaFlow
18 News #PharmaBuzz

GLOBAL SALES INFORMATION

55 Regulatory FDF Prices

55 Regulatory FDF Prices

MARKET PLACE

15 APIs, 1 FDF Dossiers, 5 EXCIPIENTS

15 APIs
1 FDF Dossiers
5 EXCIPIENTS

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

Xls

Filters

×

FILTER:

filter

Company Name

1
ALL
1
Evofem Biosciences

filter

Year

1
ALL
1
2025

filter

DEALS // DEV.

1
ALL
1
Deals

filter

Country

1
ALL
1
U.S.A

filter

Sponsor

1
ALL
1
Windtree Therapeutics

filter

Therapeutic Area

1
ALL
1
Obstetrics/Gynecology (Women’s Health)

filter

Study Phase

1
ALL
1
Approved FDF

filter

Deal Type

1
ALL
1
Licensing Agreement

filter

Product Type

1
ALL
1
Other Small Molecule

filter

Dosage Form

1
ALL
1
Vaginal Gel

filter

Lead Product

1
ALL
1
L-Lactic Acid

filter

Target

1
ALL
1
Vaginal pH

All Developments

Therapeutic Area by Lead Product

Sample Tooltip

Study Phase by Lead Product

Sample Tooltip

Company by Lead Product

Sample Tooltip

Top Deals by Deal Size (USD bn)

Sample Tooltip

Reset All

01

Evofem Biosciences

U.S.A

Pharma Live Expo

Not Confirmed

Evofem Biosciences

U.S.A

Pharma Live Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : L-Lactic Acid,Lactic Acid,Potassium Bitartrate

Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

Study Phase : Approved FDF

Sponsor : Windtree Therapeutics

Deal Size : Undisclosed

Deal Type : Licensing Agreement

Windtree Signs License & Supply Deal for FDA Approved Small Biotech Product

Details : Under the licensing agreement, Windtree will hold the exclusive rights of Phexxi (lactic acid, citric acid, and potassium bitartrate) vaginal gel. It is being indicated to prevent prgenancy.

Product Name : Phexxi

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

March 20, 2025

Lead Product(s) : L-Lactic Acid,Lactic Acid,Potassium Bitartrate

Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

Highest Development Status : Approved FDF

Sponsor : Windtree Therapeutics

Deal Size : Undisclosed

Deal Type : Licensing Agreement

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Privacy policy
Terms and conditions
Disclaimers
Ask Us!